The whitepaper, How Blockchain Can Connect and Optimize Healthcare, details how blockchain can, and is, revolutionizing the healthcare industry. The report outlines:
The report is co-authored by specialists from Luxoft and Appian, with contributions lead by Sam Mantle, Managing Director of Digital Enterprise at Luxoft, Gianni Piccininni, Managing Director of Healthcare and Life Sciences at Luxoft and Global Leader for the Healthcare Provider and Payer Industries at Appian, Cate McConnell.
Sam spent 11 years working for pharmaceutical giant Novartis, leading global technology strategy and functions for its Vaccines and R&D divisions before joining Luxoft. Gianni leads Luxoft’s Healthcare division and is a health IT business leader with over 20 years of experience in Healthcare and Life Sciences. Cate McConnell is an expert in helping health insurance companies to realize their digital transformation strategies with over 20 years’ industry experience.
Download the full whitepaper here.
To find out more about Luxoft’s Healthcare Division visit its website.
To find out more about Appian’s Healthcare Division visit its website.
Luxoft (NYSE:LXFT) is a global IT service provider of innovative technology solutions that delivers measurable business outcomes to multinational companies. Its offerings encompass strategic consulting, custom software development services, and digital solution engineering. Luxoft enables companies to compete by leveraging its multi-industry expertise in the financial services, automotive, communications, and healthcare & life sciences sectors. Its managed delivery model is underpinned by a highly-educated workforce, allowing the Company to continuously innovate upwards on the technology stack to meet evolving digital challenges.
Luxoft has approximately 12,900 employees across 42 offices in 22 countries within five continents, with its operating headquarters office in Zug, Switzerland. For more information, please visit the website.
Luxoft Forward-Looking Statements
This news release of Luxoft Holding, Inc (“Luxoft”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include information about possible or assumed future results of our business and financial condition, as well as the results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements are subject to, without limitation, the risk factors discussed under the heading “Risk Factors” in Luxoft’s Annual Report on Form 20-F for the year ended March 31, 2018 and other documents filed with or furnished to the Securities and Exchange Commission by Luxoft. Except as required by law, Luxoft undertakes no obligation to publicly update any forward-looking statements for any reason after the date of this news release whether as a result of new information, future events or otherwise.